Related Experiment Video
Updated: Sep 28, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
Interaction of hepatitis B virus X protein with damaged DNA-binding protein p127: structural analysis and
François Bergametti1, Julie Bianchi, Catherine Transy
1Unité de Recombinaison et Expression Génétique (INSERM U163), Institut Pasteur, Paris, France.
Abstract:
The hepatitis B virus X protein is a multifunctional protein that is essential for natural infection and has also been implicated in liver cancer development. Previous studies have identified the DDB1 subunit of the damaged-DNA binding complex as a critical partner of X protein in the infection process, X-mediated cytotoxicity and stability of the viral protein. Here, we investigated the structural and functional constraints of X-DDB1 interaction using various mutational analyses. Our data show that the interaction interface of X with DDB1 is confined to a 15-residue epitope. All substitutions responsible for loss of binding mapped to this core-binding domain. In contrast, a marked increase in affinity for DDB1 resulted from substitutions at clustered positions lying close to the DDB1-binding epitope and correlated with loss of apoptotic potential. Selection of mutations in DDB1 that partially rescue the binding defect of an X mutant gave further insight into the contacts established between the two proteins. Importantly, both the core-binding domain of X and the gain-of-affinity X mutants inhibited DDB1- mediated stabilization of wild-type X protein. These X protein derivatives thus provide the basis for the development of therapeutic agents that antagonize X function through competitive inhibition of X-DDB1 interaction.
Insights
Hepatitis B virus X protein interacts with DDB1. Mutational analysis reveals a core-binding domain and gain-of-affinity mutants that inhibit X-DDB1 interaction, offering potential therapeutic strategies.
Area of Science:
- Virology
- Molecular Biology
- Hepatocellular Carcinoma Research
Background:
- Hepatitis B virus X protein (HBx) is crucial for infection and liver cancer.
- HBx interacts with the DDB1 subunit of the DNA damage-binding complex, affecting viral stability and cytotoxicity.
Purpose of the Study:
- To investigate the structural and functional basis of the HBx-DDB1 interaction.
- To identify key residues and regions involved in HBx-DDB1 binding and function.
Main Methods:
- Site-directed mutagenesis of the Hepatitis B virus X protein.
- Analysis of HBx-DDB1 binding affinity and interaction interfaces.
- Assessment of HBx mutants' effect on DDB1-mediated stabilization and apoptotic potential.
Main Results:
- The HBx-DDB1 interaction interface is a 15-residue epitope.
- Mutations within this epitope abolish binding, while substitutions nearby increase affinity but reduce apoptotic activity.
- Both core-binding and high-affinity HBx mutants inhibit DDB1-mediated stabilization of wild-type HBx.
Conclusions:
- The HBx-DDB1 interaction is finely tuned, with distinct regions governing binding affinity and functional outcomes.
- HBx derivatives that competitively inhibit HBx-DDB1 interaction show therapeutic potential against Hepatitis B virus infection and associated liver cancer.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly
Single-Strand DNA Binding Proteins